FDA panel fails to recommend adefovir approval. Food and Drug Administration.
Highleyman
L
L
D000225:Adenine / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D019380:Anti-HIV Agents / Q000009:adverse effects / Q000627:therapeutic use*; D017277:Drug Approval; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D007674:Kidney Diseases / Q000139:chemically induced; D016879:Salvage Therapy; D014486:United States Food and Drug Administration
D019380:Anti-HIV Agents; D000225:Adenine